ADULT ADHD TREATMENT · NON-STIMULANT OPTIONS · DUAL DIAGNOSIS
Residential ADHD treatment for adult with co occurring substance use, Adderall tolerance issues or executive function issues. We offer treatment for the underlying issues along with stimulant and non-stimulant medication options through our 30 to 90 day program.Call (844) 501-5005Verify Insurance
Joint Commission Accredited
Substance-Specific Protocols
24/7 Medical Team
Private Gated Estate
Diagnosis That’s Actually Diagnostic
The initial step in treating co-occuring ADHD is to prove a legitimate diagnosis and confirm that the prescription use was not just a short-term fix for an unrelated issue but a long-term struggle. More than just a brief 10-minute appointment with a prescription for a stimulant at the end. Evaluation occurs with structured clinical interview (DIVA-5 or similar), self-report measures (ASRS, BAARS-IV), collateral history, objective testing (QbCheck or CPT-3) and differential diagnosis dismissing depression, anxiety, sleep disorders or stimulant misuse.
Residential treatment for ADHD is also an appropriate option when ADHD has reached the level of functional collapse or stimulant abuse (eg, illegal acquisition of prescription medication) has complicated the clinical picture. A number of our clients arrive to us with many years of Adderall tolerance, long past the therapeutic dosage, or a larger substance use disorder that has progressed into methamphetamine usage and amphetamine use disorders. The escalations of care are too high for outpatient treatment of ADHD. This is why, when this happens as a part of an organized environment and with every day clinical interest which includes medical supervision medication technique selections are safe.
ADHD is a predisposing factor in concurrent substance abuse. Studies show that almost half of people with ADHD have at least one lifetime substance use disorder. Though they may be preliminarily treated in sequence, this fails — untreated ADHD drives relapse; thusly, we integrate ADHD treatment and substance work.
There is a systemic underdiagnosis due to women with ADHD. It is all about inattentive presentation, internalizing symptoms or masking which last through school and early career. A lot of women are only diagnosed with ADHD in their mid-30s after years(5) of depleted sustained-masking. The women and ADHD treatment track discusses both diagnosis and subsequent identity work needed to catch up. It works for adult ADHD treatment when the diagnosis is correct and the medication strategy is not reflexive — meaning that so much of adult ADHD treatment is just Adderall by reflex.
DIVA-5 structured interview. Self-report instruments (ASRS, BAARS-IV). Collateral history when family, partners, friends or other supporters can contribute. Continuous Performance Test (QbCheck or CPT-3) to ensure an objective baseline. Differential diagnosis ruling out depression, anxiety, sleep disorders, and stimulant misuse. these evaluations are done at the start of treatment and ongoing through all levels of care.
First-line stimulants only when appropriate and medically indicated. Non-stimulant ADHD medication (atomoxetine, guanfacine). Genesight pharmacogenomic testing when prior trials have been inconsistent. along with Dose titration in a controlled setting.
Executive function coaching is the practical-skills building work necessary for many clients with co-occuring ADHD, these include time blocking, Task initiation strategies, Working memory scaffolding, Accountability structures. Most adult ADHD treatment outcomes improve with executive function coaching as much as with medication, though the two work better together in a supportive setting.
For ADHD with a co-occuring substance use disorder, the substance work runs parallel to ADHD treatment, not after. Discharge with prescriber, therapist, executive function coach, and ongoing medication monitoring. Standing weekly check-in for the first month. See stimulant residential for clients whose stimulant misuse drove the admission.
For clients whose ADHD treatment turned into stimulant misuse through escalating doses, Combining with alcohol or other substances — the path forward isn’t abstinence-only or stimulant-as-usual. Sometimes a non-stimulant ADHD medication is appropriate. In some cases monitored stimulant treatment with a clear accountability framework works. The clinical question is what’s safer than the pattern that brought you here. See our stimulant residential page.
Adderall tolerance — when prescribed Adderall stops working at therapeutic doses and dose escalation hasn’t helped. The rebuild often involves a structured break, sometimes a switch to non-stimulant medication, and addressing what drove the tolerance development (sleep deprivation, stress, sometimes underlying depression that the Adderall may have been masking). Residential ADHD treatment makes the rebuild safer than home-managed tolerance work.
Women and ADHD treatment is a clinical specialty in its own right. Women are systematically underdiagnosed because the criteria were validated primarily on hyperactive-presentation males. Adult women often present with inattentive symptoms, anxiety masking, perfectionism collapse, and identity disruption that has led to a substance use disorder. When these underlying issues are finally diagnosed. The catch-up work isn’t surface level, often it can be a full psychological reorganization that ADHD treatment supports.
Most adult ADHD cases have at least one co-occuring condition. Depression (very common). Anxiety (very common). Sleep disorders. In other cases we find that bipolar has been misdiagnosed as ADHD or vice versa. Treatment plans address these concerns in parallel.
Resort-Style Pool
Spa, Sauna & Wellness Suite
Chef-Prepared Meals DailyConfidential admissions, 24/7. We’ll walk you through every step.Call (844) 501-5005Verify Insurance
Residential adult ADHD treatment starts with diagnosis — DIVA-5 structured interview, self-report instruments (ASRS, BAARS-IV), continuous performance testing (QbCheck or CPT-3), and differential diagnosis ruling out depression, anxiety, sleep disorders, and stimulant misuse. Medication strategy follows: Either a non-stimulant ADHD path or a highly structured continuation of stimulant prescription with a new framework. Regardless of medication pathway the real difference is made through executive function coaching and dual-diagnosis treatment for the conditions run alongside. the positive outcomes from this clinical work track alongside medication. not skills work or medication alone.
Adderall tolerance occurs when the prescribed Adderall ceases production of the therapeutic effect at doses that previously worked. Eventually dose escalation stops working. The rebuild often involves a structured medication break, sometimes a switch to methylphenidate-class stimulants or non-stimulant ADHD medication coupled with addressing what drove the tolerance development (sleep deprivation, chronic stress, sometimes underlying depression the Adderall was masking). Residential ADHD treatment makes the rebuild safer than home-managed tolerance work because withdrawal symptoms during the break can include severe fatigue, anhedonia, and depression. The 30-day structured break with clinical support typically resets sensitivity for many clients.
ADHD and substance abuse comorbidity affects roughly half of young adults with an ADHD diagnosis over a lifetime. The treatment runs in parallel — sequential approaches fail because untreated ADHD drives substance relapse. and a medication only approach only leads to further escalation of the substance use disorder Non-stimulant ADHD medication is often the safer choice for clients with significant substance-use history. When stimulant medication is necessary, a structured monitoring along with a controlled-dose protocol reduce abuse risk. Either approach coupled with comprehensive clinical interventions help with the impulsivity and time-management deficits that drive both ADHD and substance use patterns. See our recovery programs hub for the substance-side details.
Most major commercial insurers cover residential ADHD treatment under MHPAEA mental-health parity laws when comorbid conditions establish medical necessity. Coverage typically includes Anthem Blue Cross Blue Shield, Aetna, Cigna, Carelon Behavioral Health, UnitedHealthcare, Empire Plan / NYSHIP, and Optum Behavioral Health. ADHD-only admissions face stricter medical-necessity criteria; ADHD with comorbid depression, anxiety, or substance use disorder usually qualifies for coverage more easily. Same-day insurance verification is standard at GEVS. To start the verification process, see our verify your insurance page or call (844) 501-5005.
Continue exploring
These programs pair naturally with the path you are on. Use them to keep exploring, or talk with admissions about a complete plan.
Not sure which program fits? Our admissions team can review the situation and verify benefits while you are on the phone — usually in under 15 minutes.
Verify your insurance same-day →
Or call (844) 501-5005
